TG-43 Dosimetric Characteristics of Mills' Newly Designed pd-103 Brachytherapy Source

Grants and Contracts Details

StatusFinished
Effective start/end date4/15/03 → 10/31/04

Funding

  • Mills Biopharmaceutical Inc: $24,200.00